Literature DB >> 19091458

Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Shu-Chun Chuang1, Carlo La Vecchia, Paolo Boffetta.   

Abstract

The incidence of liver cancer is high in all low-resource regions of the world, with the exception of Northern Africa and Western Asia. The estimated worldwide number of new cases of liver cancer in 2002 is 600,000, of which 82% are from developing countries. Given the poor survival from this disease, the estimated number of deaths is similar to that of new cases. Hepatocellular carcinoma (HCC) is the main form of liver cancer. A part from chronic infections with Hepatitis B and Hepatitis C viruses, which are the main causes of HCC, contamination of foodstuff with aflatoxins, a group of mycotoxins produced by the fungi Aspergillus flavus and Aspergillus parasiticus, is an important contributor to HCC burden in many low-income country. Alcoholic cirrhosis is an important risk factor for HCC in populations with low prevalence of HBV and HCV infection, and the association between tobacco smoking and HCC is now established. Diabetes is also related to an excess risk of HCC and the increased prevalence of overweight and obesity likely contributes to it. The second most important type of liver cancer is cholangiocarcinoma, whose main known cause is infestation with the liver flukes, Opistorchis viverrini and Clonorchis sinensis, which is frequent in some areas in South-East Asia. Angiosarcoma is a rare form of liver cancer whose occurence is linked to occupational exposure to vinyl chloride.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091458     DOI: 10.1016/j.canlet.2008.10.040

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  127 in total

1.  Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.

Authors:  Shan Gao; Wan-Shui Yang; Freddie Bray; Puthiery Va; Wei Zhang; Jing Gao; Yong-Bing Xiang
Journal:  Eur J Epidemiol       Date:  2011-12-10       Impact factor: 8.082

2.  Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis.

Authors:  Shu-Chun Chuang; Yuan-Chin Amy Lee; Mia Hashibe; Min Dai; Tongzhang Zheng; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

Review 3.  A review of cancer in U.S. Hispanic populations.

Authors:  Robert W Haile; Esther M John; A Joan Levine; Victoria K Cortessis; Jennifer B Unger; Melissa Gonzales; Elad Ziv; Patricia Thompson; Donna Spruijt-Metz; Katherine L Tucker; Jonine L Bernstein; Thomas E Rohan; Gloria Y F Ho; Melissa L Bondy; Maria Elena Martinez; Linda Cook; Mariana C Stern; Marcia Cruz Correa; Jonelle Wright; Seth J Schwartz; Lourdes Baezconde-Garbanati; Victoria Blinder; Patricia Miranda; Richard Hayes; George Friedman-Jiménez; Kristine R Monroe; Christopher A Haiman; Brian E Henderson; Duncan C Thomas; Paolo Boffetta
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

4.  Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysis.

Authors:  Shuzhen Liu; Yongchun Cui; Baohong Yang; Ping Chai; Zheng Su; Qianqian Zhang; Dejie Zheng; Rui Li; Guohua Yu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.

Authors:  Xing Liu; Aileen Baecker; Ming Wu; Jin-Yi Zhou; Jie Yang; Ren-Qiang Han; Pei-Hua Wang; Zi-Yi Jin; Ai-Min Liu; Xiaoping Gu; Xiao-Feng Zhang; Xu-Shan Wang; Ming Su; Xu Hu; Zheng Sun; Gang Li; Alan Fu; Su Yon Jung; Lina Mu; Na He; Liming Li; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Liver Int       Date:  2019-07-10       Impact factor: 5.828

6.  CRKII overexpression promotes the in vitro proliferation, migration and invasion potential of murine hepatocarcinoma Hca-P cells.

Authors:  Zanmei Zhou; Xiuyan Sun; Chunmei Guo; Ming-Zhong Sun; Shuqing Liu
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

7.  Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.

Authors:  Zihan Zhou; Xianguo Zhou; Yanji Jiang; Moqin Qiu; Xiumei Liang; Qiuling Lin; Qian Guo; Cunli Nong; Rongrui Huo; Qian Chen; Haizhou Liu; Yingchun Liu; Shaoliang Zhu; Mengyun Wang; Hongping Yu
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

8.  Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Melanie B Thomas; Deborah Jaffe; Michael M Choti; Jacques Belghiti; Steven Curley; Yuman Fong; Gregory Gores; Robert Kerlan; Phillipe Merle; Bert O'Neil; Ronnie Poon; Lawrence Schwartz; Joel Tepper; Francis Yao; Daniel Haller; Margaret Mooney; Alan Venook
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

Review 9.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

10.  Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway.

Authors:  Yulan Zhen; Qiaomei Wu; Yiqian Ding; Wei Zhang; Yuansheng Zhai; Xiaoxiong Lin; Yunxia Weng; Ruixian Guo; Ying Zhang; Jianqiang Feng; Yiyan Lei; Jingfu Chen
Journal:  Oncol Lett       Date:  2018-03-02       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.